BioCentury
ARTICLE | Clinical News

CTX stem cells: Ph II PISCES II data

February 17, 2017 7:57 PM UTC

ReNeuron reported top-line data from the open-label, U.K. Phase II PISCES II trial in patients who had an ischemic stroke 2-13 months prior to treatment showing that 3 of 21 patients who received a si...

BCIQ Company Profiles

ReNeuron Group plc